WCG Clinical Announces Relaunch of FDAnews as the Premier Source for Drug and Device Insights
WCG Clinical Announces Relaunch of FDAnews as the Premier Source for Drug and Device Insights
The impetus for these changes is in response to feedback from the publications' readers. "Each business day, the new FDAnews will deliver precisely what pharmaceutical and medical device manufacturers have told us they need to know about regulatory compliance and good manufacturing practices," said PRINCETON, N.J., April 3, 2023 /PRNewswire/ -- WCG Clinical announces the relaunch of its publication FDAnews, a trusted resource for pharmaceutical and medical device insights for more than 50 years. The relaunch will combine the products Drug Industry Daily, Device Daily Bulletin Premium, Drug Daily Bulletin and Device Daily Bulletin into one content destination at FDAnews.com.
新泽西州普林斯顿，2023 年 4 月 3 日 /PRNewswire/ — WCG Clinical 宣布重新发布其出版物 FDANews， 50 多年来值得信赖的制药和医疗设备洞察资源。重新发布将合并这些产品 《制药行业日报》、《设备日报》高级版， 《毒品日报》 和 设备每日公告 进入一个内容目的地 FDanews.com。
In addition to free, breaking news headlines that are available to all readers, FDAnews' premium customers will have access to daily content on:
除了向所有读者提供的免费突发新闻头条外， FDaNews' 高级客户将可以访问以下内容的每日内容：
- Draft and final guidance from the FDA and other regulatory agencies
- Company mergers and technology developments
- FDA budgets and spending, including proposals and approvals by Congress and the President
- FDA inspection policies, practices, and enforcement activities
- Global enforcement and supply chain trends
- Pharmacovigilance developments
- 来自FDA和其他监管机构的指南草案和最终指南
- 公司合并和技术发展
- 美国食品和药物管理局的预算和支出，包括国会和总统的提案和批准
- FDA 的检查政策、做法和执法活动
- 全球执法和供应链趋势
- 药物警戒的发展
Additional premium features provided by FDAnews' team of industry journalists and subject matter experts from its newly formed editorial board will include:
提供的其他高级功能 FDaNews' 来自其新成立的编辑委员会的行业记者和主题专家团队将包括：
- In-depth exposés into essential pharmaceutical and device issues
- Reports and perspective on Form 483s, warning letters, recalls, and FDA policy notices and other reports
- Thought pieces, columns, and exclusive perspective on trending topics
- Excerpts of best-selling FDAnews webinar and book content
- 深入了解基本的药品和器械问题
- 483 表格、警告信、召回、FDA 政策通知和其他报告的报告和观点
- 关于热门话题的思想文章、专栏和独家观点
- 畅销书摘录 FDANews 网络研讨会和书籍内容
The impetus for these changes is in response to feedback from the publications' readers. "Each business day, the new FDAnews will deliver precisely what pharmaceutical and medical device manufacturers have told us they need to know about regulatory compliance and good manufacturing practices," said Terri Moench, RPh, MS, President, Research Solutions for WCG. "Beyond the news, it is our goal is to offer the interpretation of industry changes that manufacturing professionals need to stay in compliance and thrive."
这些变化的推动力是对出版物读者的反馈的回应。 “每个工作日，新的 FDANews 将提供制药和医疗器械制造商告诉我们他们需要了解的监管合规性和良好生产规范。” WCG研究解决方案总裁RpH、MS Terri Moench说。“除了新闻之外，我们的目标是为制造业专业人员保持合规和蓬勃发展所需的行业变化提供解读。”
Readers who are not yet subscribed for premium content can visit the website daily for free headlines or sign up for a collection of the week's free stories with the newsletters FDAnews, Drug Weekly, or FDAnews Device Weekly.
尚未订阅优质内容的读者可以每天访问该网站以获取免费头条新闻，也可以通过时事通讯注册本周的免费故事集 FDANews，《毒品周刊》， 要么 FDANews 设备周刊。
Individual subscriptions, customized multi-user, and company licenses to FDAnews are also available. Contact Will Tuttle, Business Development Representative at [email protected] or +1 612.216.2948 to receive a custom quote.
个人订阅、自定义多用户和公司许可证 FDANews 也可用。致电 [email protected] 或 +1 612.216.2948 联系业务发展代表威尔·塔特尔获取定制报价。
About WCG FDAnews:
WCG FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on WCG FDAnews' newsletters, books, databases, webinars and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations. Learn more at fdanews.com.
关于 WCG FDANews:
WCG FDANews 是为受美国食品药品管理局和欧洲药品管理局监管行业的高管提供国内和国际监管、立法和商业新闻和信息的主要提供商。制药和医疗器械专业人士信赖 WCG FDANews'时事通讯、书籍、数据库、网络研讨会和会议，以遵守国际标准和FDA复杂而不断变化的法规。要了解更多信息，请访问 fdanews.com。
About WCG:
WCG is the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research. Comprised of two divisions, the industry's first central IRB – WCG IRB – and first clinical services organization, WCG enables biopharmaceutical companies, CROs, and institutions to advance the delivery of new treatments and therapies to patients, while maintaining the highest standards of human participant protection. For more information, please visit , or follow us on Twitter @WCGClinical or LinkedIn.
关于 WCG：
WCG是全球领先的解决方案提供商，这些解决方案可以显著提高临床研究的质量和效率。WCG由两个部门组成，即业界第一个中央IRB（WCG IRB）和第一个临床服务组织，使生物制药公司、CRO和机构能够推进向患者提供新疗法和疗法，同时保持人类参与者保护的最高标准。欲了解更多信息，请访问或在 Twitter @WCGClinical 或 LinkedIn 上关注我们。
SOURCE WCG
来源 WCG
译文内容由第三方软件翻译。
